Respiratory

Delivering systemic bronchodilators, mucoregulators, and leukotriene pathway antagonists, our respiratory therapy focus restores pulmonary airflow and manages chronic respiratory illnesses including bronchial asthma and COPD.

Product Portfolio

Formulation

DASLIN NF 100ML

Each 5 ml contains Loratadine USP 5mg ; Ambroxol HCL IP 30mg ;Guaiphenesin IP 50mg, Menthol IP 0.5mg

RPGLS FormulationsDetails

Formulation

DASLIN CDT

Each 5 ml contains Codeine Phosphate IP 10mg Triprolidine Hydrochloride IP 1.25 mg

RPGLS FormulationsDetails

Formulation

RINOSTAT+TABS

Each uncoated tablet contains : Paracetamol IP -- 500mg, Phenylephrine Hydrochloride IP - 5mg, Caffeine (Anhydrous)IP - 30mg, Diphenhydramine Hydrochloride IP -- 25mg & Excipients -- q.s

RPGLS FormulationsDetails

Formulation

ROMILAST B-10 TABS

Each uncoated tablet contains Montelukast Sodium IP equivalent to Montelukast 10mg+Bambuterol Hydrochoride BP 10mg, Colour Ferric Oxide Yellow USP-NF

RPGLS FormulationsDetails

Formulation

ROMILAST B-5 TABS

Each uncoated tablet contains Montelukast Sodium IP equivalent to Montelukast 5 mg+Bambuterol Hydrochoride IP 10mg, Colour Ferric Oxide Yellow.

RPGLS FormulationsDetails

Formulation

ROMILAST FX TAB 10MG

Each film coated tablet contains Montelukast sodium IP equivalent to Montelukast 10mg + Fexofenadine HCL IP 120mg, Excepients : QS colour : Ferric Oxide yellow USP NF & Titanium Dioxide IP

RPGLS FormulationsDetails

Formulation

ROMILAST L TAB 10MG

Each film coated tablet contains Montelukast sodium IP equivalent to Montelukast 10mg + Levocetrizine Dihydrochloride IP 5mg, Excipients QS, Colour: Ferric oxide (yellow). USP-NF and Titanium Dioxide IP.

RPGLS FormulationsDetails

Formulation

ROMILAST L4 TAB 2.5MG

Each uncoated tablet contains Levocetrizine Hydrochoride IP 2.5mg + Monotelukast Sodium IP equivalent to Monotelukast 4 mg . Excipeints QS.

RPGLS FormulationsDetails

Showing 8 of 14 products